NCT07039292 Clinical Alternatives for Reducing Harm Using E-cigarettes
| NCT ID | NCT07039292 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 208 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2029-05-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
For patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching completely from cigarettes to e-cigarettes, among oncology outpatients who smoke and refuse traditional tobacco treatment. This study is a type 1 hybrid effectiveness-implementation trial among oncology outpatients at an NCI-designated cancer center who smoke and refuse all components of tobacco treatment (N=208).
Eligibility Criteria
Inclusion Criteria: * age 21+, * identified as smoking in their medical record and self-report of current smoking within the past 30 days * refused traditional treatment options through the opt-out HCC Tobacco Treatment Program * English speaking; Exclusion Criteria: * currently taking part in any TTP or using cessation medication (i.e., taking NRT or other cessation medications, enrolled in the Quitline, or in another study), * use of e-cigarettes in the past 30 days, * currently imprisoned, * pregnant women.